vs
KKR Real Estate Finance Trust Inc.(KREF)与Organogenesis Holdings Inc.(ORGO)财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是KKR Real Estate Finance Trust Inc.的1.4倍($37.2M vs $25.8M),KKR Real Estate Finance Trust Inc.同比增速更快(-26.6% vs -57.1%),过去两年KKR Real Estate Finance Trust Inc.的营收复合增速更高(-18.8% vs -46.5%)
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台,主要发起、收购并管理优先担保商业地产贷款组合,抵押物多为美国各地的优质机构级商业地产,通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
KREF vs ORGO — 直观对比
营收规模更大
ORGO
是对方的1.4倍
$25.8M
营收增速更快
KREF
高出30.5%
-57.1%
两年增速更快
KREF
近两年复合增速
-46.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $25.8M | $37.2M |
| 净利润 | $-26.2M | — |
| 毛利率 | — | 30.8% |
| 营业利润率 | -105.1% | -185.1% |
| 净利率 | -101.7% | — |
| 营收同比 | -26.6% | -57.1% |
| 净利润同比 | -229.6% | — |
| 每股收益(稀释后) | $-0.49 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KREF
ORGO
| Q1 26 | — | $37.2M | ||
| Q4 25 | $25.8M | $225.6M | ||
| Q3 25 | $25.3M | $150.9M | ||
| Q2 25 | $30.2M | $101.0M | ||
| Q1 25 | $31.3M | $86.7M | ||
| Q4 24 | $35.1M | $126.7M | ||
| Q3 24 | $37.0M | $115.2M | ||
| Q2 24 | $40.4M | $130.2M |
净利润
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-26.2M | $43.7M | ||
| Q3 25 | $13.8M | $21.6M | ||
| Q2 25 | $-29.7M | $-9.4M | ||
| Q1 25 | $-4.9M | $-18.8M | ||
| Q4 24 | $20.3M | $7.7M | ||
| Q3 24 | $-7.4M | $12.3M | ||
| Q2 24 | $25.8M | $-17.0M |
毛利率
KREF
ORGO
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
营业利润率
KREF
ORGO
| Q1 26 | — | -185.1% | ||
| Q4 25 | -105.1% | 28.1% | ||
| Q3 25 | 50.4% | 13.7% | ||
| Q2 25 | -101.3% | -12.5% | ||
| Q1 25 | -18.3% | -30.9% | ||
| Q4 24 | 55.8% | 8.1% | ||
| Q3 24 | -19.6% | 5.4% | ||
| Q2 24 | 63.3% | -10.7% |
净利率
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | -101.7% | 19.4% | ||
| Q3 25 | 54.4% | 14.3% | ||
| Q2 25 | -98.5% | -9.3% | ||
| Q1 25 | -15.5% | -21.7% | ||
| Q4 24 | 57.7% | 6.1% | ||
| Q3 24 | -20.0% | 10.7% | ||
| Q2 24 | 63.9% | -13.1% |
每股收益(稀释后)
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-0.49 | $0.31 | ||
| Q3 25 | $0.12 | $0.11 | ||
| Q2 25 | $-0.53 | $-0.10 | ||
| Q1 25 | $-0.15 | $-0.17 | ||
| Q4 24 | $0.22 | $0.05 | ||
| Q3 24 | $-0.19 | $0.09 | ||
| Q2 24 | $0.29 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $91.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | — |
| 总资产 | $6.5B | $520.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
KREF
ORGO
| Q1 26 | — | $91.4M | ||
| Q4 25 | $84.6M | $93.7M | ||
| Q3 25 | $204.1M | $63.7M | ||
| Q2 25 | $107.7M | $73.1M | ||
| Q1 25 | $106.4M | $110.0M | ||
| Q4 24 | $104.9M | $135.6M | ||
| Q3 24 | $108.8M | $94.3M | ||
| Q2 24 | $107.2M | $89.9M |
总债务
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
股东权益
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $300.1M | ||
| Q3 25 | $1.2B | $255.1M | ||
| Q2 25 | $1.2B | $233.2M | ||
| Q1 25 | $1.3B | $242.9M | ||
| Q4 24 | $1.3B | $262.9M | ||
| Q3 24 | $1.4B | $278.5M | ||
| Q2 24 | $1.4B | $263.5M |
总资产
KREF
ORGO
| Q1 26 | — | $520.0M | ||
| Q4 25 | $6.5B | $598.7M | ||
| Q3 25 | $6.5B | $509.8M | ||
| Q2 25 | $6.8B | $461.1M | ||
| Q1 25 | $6.6B | $467.4M | ||
| Q4 24 | $6.4B | $497.9M | ||
| Q3 24 | $6.8B | $446.3M | ||
| Q2 24 | $7.1B | $443.2M |
负债/权益比
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $72.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $72.3M | $39.4M | ||
| Q3 25 | $18.5M | $3.1M | ||
| Q2 25 | $21.1M | $-32.9M | ||
| Q1 25 | $15.9M | $-19.9M | ||
| Q4 24 | $132.6M | $10.9M | ||
| Q3 24 | $49.1M | $8.7M | ||
| Q2 24 | $30.6M | $4.7M |
自由现金流
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | $34.8M | ||
| Q3 25 | — | $844.0K | ||
| Q2 25 | — | $-36.5M | ||
| Q1 25 | — | $-23.6M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $6.1M | ||
| Q2 24 | — | $2.9M |
自由现金流率
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | 15.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | -36.1% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 2.2% |
资本支出强度
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.4% |
现金转化率
KREF
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | 0.90× | ||
| Q3 25 | 1.34× | 0.14× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | 1.43× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | 1.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图